Related Experiment Videos
Hyperinsulinemic hypoglycemia: effect of epinephrine suppression.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|November 1, 1977
Summary
Epinephrine effectively inhibits insulin release in most hyperinsulinemic hypoglycemia cases, except for beta-cell carcinoma. This response difference aids in diagnosing the cause of excess insulin before surgery.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Surgical Diagnosis
Background:
- Hyperinsulinemic hypoglycemia is characterized by excessive insulin secretion.
- Distinguishing between benign (adenoma, hyperplasia) and malignant (carcinoma) causes is crucial for treatment.
Purpose of the Study:
- To investigate the differential effect of epinephrine on insulin release in patients with hyperinsulinemic hypoglycemia.
- To evaluate epinephrine's potential as a preoperative diagnostic screening tool for the underlying cause of hyperinsulinemia.
Main Methods:
- Studied the inhibitory effect of epinephrine on basal and tolbutamide-stimulated insulin release.
- Evaluated responses in 5 patients with hyperinsulinemic hypoglycemia, including those with beta-cell adenoma, hyperplasia, and carcinoma.
Main Results:
- Epinephrine inhibited both basal and tolbutamide-induced insulin release in patients with beta-cell adenoma and hyperplasia.
- Epinephrine failed to inhibit insulin release in the patient with beta-cell carcinoma.
- The maximal inhibition of basal insulin by epinephrine was observed in patients with beta-cell hyperplasia.
Conclusions:
- Epinephrine exhibits a differential inhibitory effect on insulin release based on the nature of the beta-cell lesion.
- This differential response suggests epinephrine can be a valuable preoperative screening test for diagnosing the cause of hyperinsulinemia.